Webinar Date: 02/09/2025

The Future of Neuroscience Drug Development: Opportunities and Challenges

Join Dr. Bruce Morimoto, as he takes a deep dive into the future of neuroscience drug development, providing key insights into the opportunities and challenges involved with Parkinson’s and Alzheimer’s disease therapeutic development, drug delivery across the blood brain barrier, AAV-based gene therapies, precision and personalized medicine, and biomarker discovery.

Date: 2nd September 2025

Time: 9:30 PST | 12:30 EST | 17:30 BST

The landscape of neuroscience drug development is evolving rapidly, marked by groundbreaking innovations, complex regulatory shifts, and an urgent demand for more targeted therapies.

We are pleased to invite you to an exclusive Beacon Neuroscience fireside chat, where we’ll explore these trends in depth with one of the field’s leading voices, Dr. Bruce Morimoto, Head of Drug Development at Fuku Biotech.

This thought-provoking session will uncover where the greatest opportunities lie, what roadblocks persist, and how R&D leaders can strategically navigate the future of neurotherapeutics.

 

Key Insights:

  • Parkinson’s & Alzheimer’s Disease: Navigating current challenges and exploring emerging treatment breakthroughs.
  • Crossing the Blood-Brain Barrier: Innovative approaches to drug delivery in the central nervous system.
  • AAV-Based Gene Therapies: The promise and pitfalls of gene therapy for neurological conditions.
  • Precision & Personalized Neurology: Tailoring treatments to individual patient profiles for maximum impact.
  • Biomarker Discovery: Advancing early diagnosis and progression monitoring for neurodegenerative diseases.

About the Speaker

Dr. Bruce Morimoto brings decades of leadership in neuroscience drug development. At Fuku Biotech, he spearheads programs that push the boundaries of innovation and patient-centric care. This session offers a rare opportunity to hear his direct insights on the current state — and future — of neurotherapeutic R&D.

Don’t miss your chance to be part of a pivotal discussion that will shape the next chapter in neuroscience drug development. Register now to secure your spot!

Webinar Leader

Dr. Bruce Morimoto

 

Head of Drug Development at Fuku Biotech.

 

You May Also Be Interested In…

Learn More About Neuroscience

What is Beacon Neuroscience?
  • The Most Comprehensive Way to Search the Neuroscience Drug Development Landscape: Unique search ontologies based on Neuroscience drug and trial characteristics
  • Market Leading Approach to Neuroscience Preclinical & Clinical Data Curation: Manual curation of key Neuroscience research and development data points by Neuroscience research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Neuroscience company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon Neuroscience

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search